Abstract

Tumor-infiltrating T lymphocytes (TIL) play a key role in the clinical outcome of human colorectal cancer; however, the dynamics of their recruitment along colorectal cancer clinical progression have not been fully elucidated. Tertiary lymphoid tissue (TLT) is an ectopic organized lymph node-like structure that typically forms at sites of chronic inflammation and is involved in adaptive immune responses. Its occurrence in cancer is sporadically documented and its role and clinical relevance is largely unknown. The occurrence of TLT, the correlation with TILs, and the clinical relevance were evaluated retrospectively, in a cohort study involving a consecutive series of 351 patients with stage II and III colorectal cancer. The role of TLT in lymphocyte recruitment was assessed in a preclinical model of colorectal cancer. In both human colorectal cancer and in a murine model of colorectal cancer, we identified organized TLT, highly vascularized (including high endothelial venules), and correlated with the density of CD3(+) TILs. Intravenous injection in mice of GFP splenocytes resulted in homing of lymphocytes to TLT, suggesting an active role of TLT in the recruitment of lymphocytes to tumor areas. Accordingly, TLT density and TIL infiltration correlated and were coordinated in predicting better patient's outcome among patients with stage II colorectal cancer. We provide evidence that TLT is associated with lymphocyte infiltration in colorectal cancer, providing a pathway of recruitment for TILs. TLT cooperates with TILs in a coordinated antitumor immune response, when identifying patients with low-risk early-stage colorectal cancer, thus, representing a novel prognostic biomarker for colorectal cancer.

Highlights

  • Immune infiltration is a fundamental component of solid tumors [1], its involvement in cancer progression being documented by preclinical and clinical studies

  • We provide evidence that Tertiary lymphoid tissue (TLT) is associated with lymphocyte infiltration in colorectal cancer, providing a pathway of recruitment for tumor-infiltrating lymphocytes (TILs)

  • TLT cooperates with TILs in a coordinated antitumor immune response, when identifying patients with low-risk early-stage colorectal cancer, representing a novel prognostic biomarker for colorectal cancer

Read more

Summary

Introduction

Immune infiltration is a fundamental component of solid tumors [1], its involvement in cancer progression being documented by preclinical and clinical studies. T-cell infiltration correlates with favorable prognosis in various common neoplastic diseases, including colorectal cancer [2,3,4,5], emerging as a potential immune biomarker of outcome and promising therapeutic target. Tumor-infiltrating lymphocytes (TILs) are associated with favorable prognosis [2,3,4, 6,7,8], independently by tumor–node–metastasis (TNM) stage [3, 6, 8], or only in stage II colorectal cancer [4]. Despite the documented association between TILs and the clinical outcome, the dynamics of T-cell recruitment and activation along colorectal cancer progression have not been fully elucidated

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call